DDX5 and breast cancer: Knockdown of DDX5 inhibited the processing of pri-miR-21 and resulted in accumulation of unprocessed pri-miR-21 and decreased levels of mature miR-21 in three breast cancer cell lines harboring 17q23 amplicon (Fig. 4c and Supplementary Fig. 5b).